Table 2.

Presence of Characteristic Translocations in Different Subtypes of BBCL

Histopathological Lymphoma Subtype According to:
Kiel Classification cb Lymphomaib Lymphoma BL Centrocytoid-cb Lymphoma Other BBCL All
REAL ClassificationDiffuse Large Cell Lymphoma BL bMCL Variant Other High-Grade BCL
Aberrant clones  63 (92.6%)  26 (92.9%) 10 (90.9%)  11 (100%)  6 (75.0%)  116 (92.1%) 
Complex aberrant clones* 50 (73.5%)  22 (78.6%) 2 (18.2%)  9 (81.8%)  5 (62.5%)  88 (69.8%) 
Chromosome translocations  
 t(8;14)  2 (2.9%)  6 (54.5%)  0  0  8 (6.3%)  
 t(11;14)  0  0  11 (100%)  0  11 (8.7%)  
 t(14;18) 20 (29.4%)  1 (3.6%)  2 (18.2%)  0  23 (18.3%)  
 t(3;14) 9 (12.3%)  5 (17.9%) 1 (9.1%)  0  1 (12.5%)  16 (12.7%) 
Histopathological Lymphoma Subtype According to:
Kiel Classification cb Lymphomaib Lymphoma BL Centrocytoid-cb Lymphoma Other BBCL All
REAL ClassificationDiffuse Large Cell Lymphoma BL bMCL Variant Other High-Grade BCL
Aberrant clones  63 (92.6%)  26 (92.9%) 10 (90.9%)  11 (100%)  6 (75.0%)  116 (92.1%) 
Complex aberrant clones* 50 (73.5%)  22 (78.6%) 2 (18.2%)  9 (81.8%)  5 (62.5%)  88 (69.8%) 
Chromosome translocations  
 t(8;14)  2 (2.9%)  6 (54.5%)  0  0  8 (6.3%)  
 t(11;14)  0  0  11 (100%)  0  11 (8.7%)  
 t(14;18) 20 (29.4%)  1 (3.6%)  2 (18.2%)  0  23 (18.3%)  
 t(3;14) 9 (12.3%)  5 (17.9%) 1 (9.1%)  0  1 (12.5%)  16 (12.7%) 
*

Complex aberrant clones were defined as containing 4 or more abnormalities. Balanced translocations were considered as 1 abnormality.

Including other changes of 3q27, namely t(1;3)(q34;q27), t(2;3)(q35;q27), t(3;12)(q27;q13q24), t(3;22)(q27;q11), inv(3)(q13q27), dup(3)(q21q27), r(3)(p2?q2?7), add(3)(q27).

Including unclassifiable BBCL and rare subtypes.

Close Modal

or Create an Account

Close Modal
Close Modal